Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis
Nanotechnology is in the spotlight of therapeutic innovation, with numerous advantages for tumor visualization and eradication. The end goal of the therapeutic use of nanoparticles, however, remains distant due to the limitations of nanoparticles to target cancer tissue. The functionalization of nan...
Main Authors: | Nora Bloise, Mohammad Okkeh, Elisa Restivo, Cristina Della Pina, Livia Visai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/2/289 |
Similar Items
-
Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages
by: Nuno Lopes, et al.
Published: (2021-02-01) -
Resources and Methods for Engineering “Designer” Glycan-Binding Proteins
by: Ruben Warkentin, et al.
Published: (2021-01-01) -
Small molecule inhibitors of mammalian glycosylation
by: Karim Almahayni, et al.
Published: (2022-12-01) -
Lectins: an effective tool for screening of potential cancer biomarkers
by: Onn Haji Hashim, et al.
Published: (2017-09-01) -
Databases and Bioinformatic Tools for Glycobiology and Glycoproteomics
by: Xing Li, et al.
Published: (2020-09-01)